• The overall incidence of heart disease has increased in India during the last 20 years and this is expected to continue.
  • Epsilon is associated with the most prominent Cardiology sites and Investigators and ensures diverse patient pool and leading lines of medical treatment.


  • Epsilon has developed sophisticated networks of gastroenterology investigators and investigative sites.
  • These sites have state of the art facilities, equipment, diagnostic tests and therapeutic procedures available for patients with GI disorders.



  • In 2000, nearly 800,000 cases were diagnosed and 550,000 people died of cancer. Tobacco-related cancers account for almost one-third of all cancers in India, predominantly head and neck, lung, and esophageal cancers. Indian women most commonly suffer from cervical, uteri and breast cancer.
  • Epsilon has experience in conducting oncology trials with experienced investigators




  • Respiratory diseases impose tremendous health burden on Indian patients. In India, rising pollution and changes in lifestyle contribute to increased levels of respiratory diseases.
  • Epsilon has significant experience in supporting clinical trials for respiratory diseases. One of the most prevalent respiratory diseases in India is Chronic Obstructive Pulmonary Disease (COPD). Other common respiratory problems in India are asthma, respiratory allergies, occupational lung diseases and bronchial hypertension


  • India has developed significant prevalence of psychiatric diseases and disorders. The World Health Organization (WHO) estimates that a minimum of 25 million people in India are in need of mental health services. Psychiatric disorders as follows: all psychoses, epilepsy, mental retardation, alcohol/drug addiction , and neurotic disorders .
  • Epsilon is associated with the most prominent sites and Investigators associated with this therapeutic area


Infectious Diseases

  • In India, the range and burden of infectious diseases are enormous. Tuberculosis, malaria, filariasis, visceral leishmaniasis, leprosy, HIV infection, and childhood cluster of vaccine-preventable diseases are given priority. Other infectious diseases that are caused by faecally transmitted pathogens (enteric fevers, cholera, hepatitis A and E viruses) and zoonoses (rabies, leptospirosis, anthrax).
  • Epsilon is associated with investigators and investigative sites experienced in this area.


  • The science of dermatology in India has evolved over the last 20 years from a specialty practice to a mainstream commercial practice with over 10,000 practitioners throughout the country. Prevalent skin diseases include Scabies, Pediculosis, Tinea, Leprosy, Vitiligo, Pityriasis Versicolor, Pityriasisalba, Dermatitis, Urticaria, Impetigo, and Boils.
  • Epsilon has experienced team to conduct a study feasibility analysis and determines the appropriate sites and availability of patients.



  • India offers doctors and eye care centers across the country offering minor to highly specialized eye care treatment. As a developing country, India has many diseases and conditions in this therapeutic area. Common forms of the diseases under ophthalmology are strabismus (crossed eyes), amblyopia (lazy eye), congenital glaucoma, congenital cataracts and trauma. The prevalence of diseases leading to blindness in India is extremely high.
  • Using sophisticated databases of detailed site information and data, Epsilon can conduct trials in this field.


  • An estimated 108 million people in the world suffer from endocrine and metabolic disorders.Diabetes mellitus is growing at an alarming rate all over the world particularly in India. It is estimated that there are currently 32 million people with diabetes in India which is projected to increase by 80 million in the year 2030.Other common diseases and disorders seen are thyroid, reproductive/infertility, obesity, lipid disorders and growth disorders.
  • Our clinical investigators have experience conducting global trials and have access to a large and diverse treatment naive patient pool


  • Epsilon has a database of highly qualified and experienced clinical investigators and urology centres.
  • We have tremendous trial experience which includes disease such as; benign prostatic hypertrophy (BPH), stress and urgency incontinence, overactive bladder (OAB), erectile dysfunction, female sexual dysfunction, nocturia, lower urinary tract symptoms (LUTS), prostatitis, urinary tract infections (UTI’s), and urologic oncology such as prostate, bladder and renal cell carcinoma